Trial Profile
A Study Investigating the Effect of Age on Regional [18F]AV-1451 PET, Pittsburgh Compound B PET and MRI Atrophy in Patients with Atypical Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2018
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary) ; Pittsburgh compound B (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 05 Oct 2018 New trial record